Eaton Vance Management Eagle Pharmaceuticals, Inc. Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $10,520 - $12,413	-236 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $504 - $625	11 Added 4.89%	236 $0
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $7,181 - $9,147	164 Added 268.85%	225 $4,000
Q2 2021 Aug 16, 2021	BUY	$36.86 - $44.5 $331 - $400	9 Added 17.31%	61 $3,000
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $2,096 - $2,650	52 New	52 $2,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.